Journal Information
Vol. 102. Issue 5.
Pages 373-377 (June - July 2011)
Share
Share
Download PDF
More article options
Vol. 102. Issue 5.
Pages 373-377 (June - July 2011)
Case Report
Full text access
Lung Involvement in Pyoderma Gangrenosum: A Case Report and Review of the Literature
Pioderma gangrenoso con afectación pulmonar: caso clínico y revisión de la literatura
Visits
6140
A. Batallaa,
Corresponding author
, A. Pérez-Pedrosab, I. García-Dovala, F.J. González-Barcalac, E. Rosóna, C. De La Torrea
a Servicio de Dermatología, Complejo Hospitalario de Pontevedra, Pontevedra, Spain
b Servicio de Anatomía Patológica, Complejo Hospitalario Universitario de Vigo, Pontevedra, Spain
c Servicio de Neumología, Complejo Hospitalario de Pontevedra, Pontevedra, Spain
This item has received
Article information
Abstract

Pyoderma gangrenosum is a neutrophilic dermatosis that, in addition to its characteristic skin manifestations, can cause visceral alterations. Our patient was a 34-year-old woman with pyoderma gangrenosum that was exacerbated by iodine and that also affected the lungs. Other published cases of lung involvement in pyoderma gangrenosum are reviewed and we discuss the possible exacerbation of this disease by iodine. Lung involvement is the most common extracutaneous manifestation of pyoderma gangrenosum and the main differential diagnosis is then with Wegener granulomatosis. It is important to remember the possible presentation of extracutaneous manifestations of pyoderma gangrenosum, including particularly lung involvement, in order to avoid subjecting a patient to aggressive diagnostic tests, at least in the initial stages.

Keywords:
Pyoderma gangrenosum
Iodine
Lung
Wegener granulomatosis
Resumen

El pioderma gangrenoso es una enfermedad perteneciente al grupo de las dermatosis neutrofílicas. Además de una clínica cutánea característica puede presentar manifestaciones viscerales. Presentamos el caso de una mujer de 34 años con un brote de pioderma gangrenoso exacerbado por yodo, con afectación pulmonar, y revisamos otros casos de pioderma gangrenoso con afectación pulmonar publicados hasta la fecha. Discutimos la posible implicación del yodo como factor de exacerbación del pioderma gangrenoso. Destacamos la afectación pulmonar como manifestación extracutánea más frecuente de esta entidad, y recordamos la granulomatosis de Wegener como principal diagnóstico diferencial del pioderma gangrenoso con afectación pulmonar. Es importante considerar la posible presentación de manifestaciones extracutáneas en el pioderma gangrenoso, entre las que destaca la afectación pulmonar, para evitar técnicas diagnósticas agresivas, al menos inicialmente.

Palabras clave:
Pioderma gangrenoso
Yoduros
Pulmón
Granulomatosis de Wegener
Full text is only aviable in PDF
References
[1.]
N. Rajan, S. Das, A. Taylor, M. Abinun, D. Spencer, A. Carmichael.
Idiopathic infantile pyoderma gangrenosum with stridor responsive to infliximab.
Pediatr Dermatol, 26 (2009), pp. 65-69
[2.]
Z.H. Liu, X.L. Lu, M.H. Fu, G.Y. Zhang, W.D. Liu.
Pyoderma gangrenosum with pulmonary involvement?.
Eur J Dermatol, 18 (2008), pp. 583-585
[3.]
C. Ferrándiz-Pulido, V. García-Patos.
Pioderma gangrenoso. Diagnóstico y tratamiento.
Piel, 23 (2008), pp. 24-29
[4.]
S. Krüger, W. Piroth, B. Amo-Takyi, C. Breuer, E.R. Schwarz.
Multiple aseptic pulmonary nodules with central necrosis in association with pyoderma gangrenosum.
Chest, 119 (2001), pp. 977-978
[5.]
S. Kanoh, H. Kobayashi, K. Sato, K. Motoyoshi, S. Aida.
Tracheobronchial pulmonary disease associated with pyoderma gangrenosum.
Mayo Clin Proc, 84 (2009), pp. 555-557
[6.]
S. Field, F.C. Powell, V. Young, L. Barnes.
Pyoderma gangrenosum manifesting as a cavitating lung lesion.
Clin Exp Dermatol, 33 (2008), pp. 418-421
[7.]
J.P. Callen, J.M. Jackson.
Pyoderma gangrenosum: an update.
Rheum Dis Clin North Am, 33 (2007), pp. 787-802
[8.]
B. Chahine, C. Chenivesse, I. Tillie-Leblond, E. Delaporte, A. Scherpereel, J.P. Grignet, et al.
Pulmonary manifestations of Pyoderma gangrenosum.
Presse Med, 36 (2007), pp. 1395-1398
[9.]
T.S. Brown, G.S. Marshall, J.P. Callen.
Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis.
J Am Acad Dermatol, 43 (2000), pp. 108-112
[10.]
M.P. Noonan, C.M. Williams, M.L. Elgart.
Fungating pustular plaques in a patient with Graves’ disease. Iododerma.
Arch Dermatol, 130 (1994), pp. 791-792
[11.]
M. Massé, V. Falanga, L.H. Zhou.
Use of topical povidone-iodine resulting in an iododerma-like eruption.
J Dermatol, 35 (2008), pp. 744-747
[12.]
A. Miranda-Romero, P. Sánchez-Sambucety, J.I. Esquivias-Gómez, M. Martínez-Fernández, C. Bajo-del Pozo, H. Aragoneses-Fraile, et al.
Vegetating iododerma with fatal outcome.
Dermatology, 198 (1999), pp. 295-297
[13.]
M.W. Chang, J.E. Miner, A. Moiin, K. Hashimoto.
Iododerma after computed tomographic scan with intravenous radiopaque contrast media.
J Am Acad Dermatol, 36 (1997), pp. 1014-1016
[14.]
A. Mirkamali, B. Martha, Y. Dutronc, T. Ponnelle, L. Pana, N. Favrolt, et al.
Abcès pulmonaire et pyoderma gangrenosum.
Med Mal Infect, 37 (2007), pp. 835-839
[15.]
K. Fukuhara, Y. Urano, S. Kimura, K. Hori, S. Arase.
Pyoderma gangrenosum with rheumatoid arthritis and pulmonary aseptic abscess responding to treatment with dapsone.
Br J Dermatol, 139 (1998), pp. 556-558
Copyright © 2011. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?